3 Firms Steer GE's $21B Sale Of Biopharma Unit To Danaher
General Electric said Monday it will unload its biopharma business in a $21.4 billion sale to Danaher, as the company continues an effort to slash debt and create a more focused...To view the full article, register now.
Already a subscriber? Click here to view full article